Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.

× No keyword cloud information.

12 in total

Review 1. Adverse effects of common medications on male fertility.

Authors: Mary K Samplaski; Ajay K Nangia
Journal: Nat Rev Urol Date: 2015-06-23 Impact factor: 14.432

Review 2. Endocrine side effects of broad-acting kinase inhibitors.

Authors: Maya B Lodish; Constantine A Stratakis
Journal: Endocr Relat Cancer Date: 2010-08-16 Impact factor: 5.678

3. Health Related Quality of Life in Patients with Onco-hematological Diseases.

Authors: Giorgio La Nasa; Giovanni Caocci; Emanuela Morelli; Elena Massa; Antonio Farci; Laura Deiana; Elisa Pintus; Mario Scartozzi; Federica Sancassiani
Journal: Clin Pract Epidemiol Ment Health Date: 2020-07-30

Review 4. Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors: Maya B Lodish
Journal: J Clin Endocrinol Metab Date: 2013-02-28 Impact factor: 5.958

5. Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event.

Authors: HeLi Liu; GuoQing Liao; ZhongShu Yan
Journal: BMC Gastroenterol Date: 2011-11-02 Impact factor: 3.067

Review 6. Gynecomastia and drugs: a critical evaluation of the literature.

Authors: Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal: Eur J Clin Pharmacol Date: 2015-04-02 Impact factor: 2.953

7. Gynecomastia in a Boy with Chronic Myeloid Leukemia during Imatinib Therapy.

Authors: Betül Tavil; Sibel Kınık; Ahmet Gözen; Lale Olcay
Journal: Turk J Haematol Date: 2013-09-05 Impact factor: 1.831

Review 8. European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors: J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal: Leukemia Date: 2016-04-28 Impact factor: 11.528

9. Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors.

Authors: Giovanni Caocci; Martino Deidda; Antonio Noto; Marianna Greco; Maria Pina Simula; Olga Mulas; Daniele Cocco; Claudia Fattuoni; Giuseppe Mercuro; Giorgio La Nasa; Christian Cadeddu Dessalvi
Journal: J Clin Med Date: 2020-04-20 Impact factor: 4.241

10. The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study.

Authors: Valérie Bernard; Justine Bouilly; Piet Kramer; Nadège Carré; Martin Schlumberger; Jenny A Visser; Jacques Young; Nadine Binart
Journal: PLoS One Date: 2016-04-01 Impact factor: 3.240